S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY
Franco Locatelli(Bambino Gesù Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Annie St. Pierre(Novartis (Switzerland)), Christine Rosko(Novartis (United States)), K. Burock(Bayer (United States)), Katsuyoshi Koh(Saitama Children's Medical Center), Alphan Küpesiz(Akdeniz University), Bülent Antmen(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ho Joon Im(Ulsan College), Hyoung Jin Kang(Seoul National University Hospital), Sunil Bhat(Narayana Health), Yoshiyuki Takahashi(Nagoya University), Tayfun Güngör, Maria Gabriela Matos(Support group for adolescents and children with cancer), Meng‐Yao Lu(National Taiwan University Hospital), Tommaso Stefanelli(Novartis (Switzerland)), Donna A. Wall(University of Manitoba)
Cited by 3
Related Papers
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473